ISRN CardiologyVolume 2013 (2013), Article ID 907848, 1 pagehttp://dx.doi.org/10.1155/2013/907848

Retraction

Retracted: Intracoronary Adenosine versus Intravenous Adenosine during Primary PCI for ST-Elevation Myocardial Infarction: Which One Offers Better Outcomes in terms of Microvascular Obstruction?

ISRN Cardiology

Received 19 November 2013; Accepted 19 November 2013

Copyright © 2013 ISRN Cardiology. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

This article entitled “Intracoronary Adenosine versus Intravenous Adenosine during Primary PCI for ST-Elevation Myocardial Infarction: Which One Offers Better Outcomes in terms of Microvascular Obstruction?” [1], published in ISRN Cardiology, has been retracted upon the authors’ request, as it was found to include erroneous data that their findings and conclusions cannot be relied upon. Additionally, the article was submitted for publication by the author Gemina Doolub without the knowledge and approval of the other author Erica Dall’Armellina.

References

G. Doolub and E. Dall'Armellina, “Intracoronary adenosine versus intravenous adenosine during primary PCI for ST-elevation myocardial infarction: which one offers better outcomes in terms of microvascular obstruction?” ISRN Cardiology, vol. 2013, Article ID 248476, 8 pages, 2013.